English Home

Health is our mission

GEDEON RICHTER'S RESPONSE TO COVID-19 PANDEMIC

Corporate strategy
Headquartered in Hungary, Gedeon Richter Plc. is an innovation-driven specialty pharmaceutical company. Vertically integrated, the company is engaged in pharmaceutical manufacturing, research and development, sales and marketing…
Read more
Products
The Company manufactures more than 200 drugs. Among our products are original, generic and licensed medicines which provide effective treatments in almost all therapeutic areas…
Read more
Biotechnology
It is vital for a company that thinks long-term to establish a presence in new areas that can serve as breakout points in the future, and biotechnology is just such an area in the pharmaceutical industry.
Read more
Career
Gedeon Richter has been a significant contributor to the Hungarian economy for more than 100 years. The Company’s success can be attributed to the management’s purposeful decision-making which has always served the implementation of long term strategy.
Read more

Press releases
Reagila named Medicine of the Year
Richter's atypical antipsychotic, Reagila, containing the active ingredient cariprazine, was awarded the prize of Medicine of the Year 2019 by the Hungarian Society for Experimental and Clinical Pharmacology (MFT). Each year, this prestigious award recognises the most advanced and effective products that have made a significant breakthrough in the treatment of a disease. The award was presented to Erik Bogsch, Chairman of the Board of Gedeon Richter Plc by Dr Péter Ferdinandy, President of MFT.

R&D
Pharmacovigilance
Our Company attaches great importance to drug safety, viewing it as a service whose goal is to ensure the conditions for the safe use of drugs for both physicians and patients and to comply with regulations and guidelines.
Research alliances
Scientific publications
Biotechnology

in Focus
Gynaecology
Gynaecological therapy is a focus area for Richter. The company has several decades of unparalleled experience in this area. The first steroid experiments were conducted by the company’s founder, Gedeon Richter himself. Our company was the first pharmaceutical company to put a contraceptive on the Hungarian market, in 1966.
Central Nervous System
Cardiology

Loading...

reports

Richter Group Report - 3 months to March 2020
580 kb 05/08/2020let lt s
Gedeon Richter Consolidated Financial Statements 2019
2903 kb 04/09/2020let lt s